CD36-TSP-HRGP interactions in the regulation of angiogenesis.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Current pharmaceutical design

• Publication date

  2007-11-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/138161207782794185PMID 18220792
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiogenesis: an organizing principle for drug discovery?

  2007cited by this paper
• ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis

  2007cited by this paper
• Developing antiangiogenic peptide drugs for angiogenesis-related diseases.

  2007cited by this paper
• Glycosylation Mediates Up-regulation of a Potent Antiangiogenic and Proatherogenic Protein, Thrombospondin-1, by Glucose in Vascular Smooth Muscle Cells*

  2007cited by this paper
• A CD36‐dependent signaling cascade is necessary for macrophage foam cell formation

  2006cited by this paper
• CD47 Is Necessary for Inhibition of Nitric Oxide-stimulated Vascular Cell Responses by Thrombospondin-1*

  2006cited by this paper
• Regulation of angiogenesis by the kallikrein-kinin system.

  2006cited by this paper
• ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2

  2006cited by this paper
• Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch

  2006cited by this paper
• Cooperative Activity of Cytotoxic Chemotherapy with Antiangiogenic Thrombospondin-I Peptides, ABT-526 in Pet Dogs with Relapsed Lymphoma

  2006cited by this paper
• Membrane Sorting of Toll-like Receptor (TLR)-2/6 and TLR2/1 Heterodimers at the Cell Surface Determines Heterotypic Associations with CD36 and Intracellular Targeting*

  2006cited by this paper
• Type I collagen is a molecular target for inhibition of angiogenesis by endogenous thrombospondin-1

  2006cited by this paper
• Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development.

  2006cited by this paper
• Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization.

  2006cited by this paper
• Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization.

  2006cited by this paper
• Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor

  2005cited by this paper
• Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer.

  2005cited by this paper
• The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.

  2005cited by this paper
• Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain

  2005cited by this paper
• Enhanced blood coagulation and fibrinolysis in mice lacking histidine‐rich glycoprotein (HRG)

  2005cited by this paper
• CD36 is a sensor of diacylglycerides

  2005cited by this paper
• Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors.

  2005cited by this paper
• The Class B Scavenger Receptor CD36 Mediates Free Radical Production and Tissue Injury in Cerebral Ischemia

  2005cited by this paper
• Inhibitors of ocular neovascularization: promises and potential problems.

  2005cited by this paper
• Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle.

  2005cited by this paper
• Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial.

  2005cited by this paper
• Ectophosphorylation of CD36 Regulates Cytoadherence of Plasmodium falciparum to Microvascular Endothelium under Flow Conditions

  2005cited by this paper
• Histidine‐rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems

  2005cited by this paper
• Drosophila RNAi Screen Reveals CD36 Family Member Required for Mycobacterial Infection

  2005cited by this paper
• Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction

  2005cited by this paper
• Metronomic Low-Dose Chemotherapy Boosts CD95-Dependent Antiangiogenic Effect of the Thrombospondin Peptide ABT-510: A Complementation Antiangiogenic Strategy

  2005cited by this paper
• Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells.

  2005cited by this paper
• Matrix-mediated canal formation in primmorphs from the sponge Suberites domuncula involves the expression of a CD36 receptor-ligand system

  2004cited by this paper
• Tumor progression: the effects of thrombospondin-1 and -2.

  2004cited by this paper
• Peptides Derived from the Histidine-Proline Domain of the Histidine-Proline-Rich Glycoprotein Bind to Tropomyosin and Have Antiangiogenic and Antitumor Activities

  2004cited by this paper
• A Fragment of Histidine-Rich Glycoprotein Is a Potent Inhibitor of Tumor Vascularization

  2004cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510.

  2004cited by this paper
• Increased CD36 protein as a response to defective insulin signaling in macrophages.

  2004cited by this paper
• Cancer without disease

  2004cited by this paper
• Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis.

  2003cited by this paper
• HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages.

  2003cited by this paper
• A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation

  2003cited by this paper
• Crystal structure of the TSP-1 type 1 repeats

  2002cited by this paper
• Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36.

  2002cited by this paper
• Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.

  2002cited by this paper
• A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid.

  2002cited by this paper
• Matricellular proteins: extracellular modulators of cell function.

  2002cited by this paper
• Identification of a Novel Family of Oxidized Phospholipids That Serve as Ligands for the Macrophage Scavenger Receptor CD36*

  2002cited by this paper
• Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor

  2002cited by this paper
• CD36 Mediates the Cardiovascular Action of Growth Hormone-Releasing Peptides in the Heart

  2002cited by this paper
• Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1.

  2002cited by this paper
• A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation

  2001cited by this paper
• Thrombospondins and tumor angiogenesis.

  2001cited by this paper
• CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

  2001cited by this paper
• Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1.

  2001cited by this paper
• Thrombospondins as matricellular modulators of cell function.

  2001cited by this paper
• Differential Roles of CD36 and αvβ5 Integrin in Photoreceptor Phagocytosis by the Retinal Pigment Epithelium

  2001cited by this paper
• Murine histidine‐rich glycoprotein: Cloning, characterization and cellular origin

  2000cited by this paper
• The thrombospondin type 1 repeat (TSR) superfamily: Diverse proteins with related roles in neuronal development

  2000cited by this paper
• Thrombospondin‐1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice

  2000cited by this paper
• Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients.

  2000cited by this paper
• Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

  2000cited by this paper
• Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma.

  2000cited by this paper
• Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma.

  2000cited by this paper
• Mechanisms of angiogenesis and arteriogenesis

  2000cited by this paper
• Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

  2000cited by this paper
• Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat.

  1999cited by this paper
• Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy.

  1999cited by this paper
• Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase.

  1999cited by this paper
• The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-β*

  1999cited by this paper
• Antiangiogenic Domains Shared by Thrombospondins and Metallospondins, a New Family of Angiogenic Inhibitors

  1999cited by this paper
• Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

  1999cited by this paper
• Expression of the thrombospondin 1 receptor CD36 is correlated with decreased stromal vascularisation in colon cancer.

  1999cited by this paper
• METH-1, a Human Ortholog of ADAMTS-1, and METH-2 Are Members of a New Family of Proteins with Angio-inhibitory Activity*

  1999cited by this paper
• A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism*

  1999cited by this paper
• PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL.

  1998cited by this paper
• Identification of a CD36-related Thrombospondin 1–binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1–specific Inhibitory Factors in Human Saliva

  1998cited by this paper
• Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes

  1998cited by this paper
• Mice That Lack Thrombospondin 2 Display Connective Tissue Abnormalities That Are Associated with Disordered Collagen Fibrillogenesis, an Increased Vascular Density, and a Bleeding Diathesis

  1998cited by this paper
• Recombinant Glutathione S-Transferase/CD36 Fusion Proteins Define an Oxidized Low Density Lipoprotein-binding Domain*

  1998cited by this paper
• Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border.

  1998cited by this paper
• Lysosomal Integral Membrane Protein II Binds Thrombospondin-1

  1998cited by this paper
• Molecular mechanisms of vasculogenesis and embryonic angiogenesis

  1997cited by this paper
• A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis

  1997cited by this paper
• Addressing tumor blood vessels

  1997cited by this paper
• CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells

  1997cited by this paper
• Domain structure and conformation of histidine-proline-rich glycoprotein.

  1996cited by this paper
• Blood-type and age affect human plasma levels of histidine-rich glycoprotein in a large population.

  1996cited by this paper
• CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium.

  1996cited by this paper
• Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators.

  1996cited by this paper
• Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation.

  1996cited by this paper
• CD36 Is Palmitoylated on Both N- and C-terminal Cytoplasmic Tails*

  1996cited by this paper
• Recombinant GST/CD36 Fusion Proteins Define a Thrombospondin Binding Domain

  1995cited by this paper
• CD36 Induction on Human Monocytes upon Adhesion to Tumor Necrosis Factor-activated Endothelial Cells (*)

  1995cited by this paper
• The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution.

  1995cited by this paper
• Inhibition of angiogenesis by thrombospondin-2.

  1995cited by this paper
• Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.

  1995cited by this paper
• Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

  1994cited by this paper
• Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease

  1994cited by this paper
• Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36.

  1993cited by this paper

• Expression profiling and antibacterial analysis of cd36 in mandarin fish, Siniperca chuatsi.

  2023cites this paper
• Cromolyn prevents cerebral vasospasm and dementia by targeting WDR43

  2023cites this paper
• Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer

  2021cites this paper
• Role of thrombospondin-1 and thrombospondin-2 in cardiovascular diseases (Review)

  2020cites this paper
• Physical resistance training-induced changes in lipids metabolism pathways and apoptosis in prostate

  2020cites this paper
• Levels of caspase-3 and histidine-rich glycoprotein in the embryo secretome as biomarkers of good-quality day-2 embryos and high-quality blastocysts

  2019cites this paper
• Physical contact between mesenchymal stem cells and endothelial precursors induces distinct signatures with relevance to the very early phase of regeneration

  2018cites this paper
• Diet-induced obesity links to ER positive breast cancer progression via LPA/PKD-1-CD36 signaling-mediated microvascular remodeling

  2017cites this paper
• Mechanisms underlying chemotherapy-induced vascular proliferation in ovarian cancer

  2017cites this paper
• Thrombospondins: A Role in Cardiovascular Disease

  2017cites this paper
• The Histidine-rich Glycoprotein in Reproduction

  2016cites this paper
• Rôle des facteurs Mdm2 et FoxOs dans la réponse angio-adaptative du tissu adipeux au cours de l’obésité et à l’exercice

  2016cites this paper
• Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma

  2016cites this paper
• Low thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancer.

  2015cites this paper
• The thrombospondin-1 receptor CD36 is an important mediator of ovarian angiogenesis and folliculogenesis

  2014cites this paper
• Animal models and the tumor microenvironment: studies of tumor-host symbiosis.

  2014cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1048 Biological Markers of Fertility

  2014influential citation
• Biological Markers of Fertility

  2014cites this paper
• Mouse Genetic Models in Studying Adipose Angiogenesis

  2013cites this paper
• Erratum: Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi's sarcoma and P. falciparum malaria

  2013cites this paper
• Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis.

  2013cites this paper
• Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi’s sarcoma and P. falciparum malaria

  2013cites this paper
• Thrombospondin-1 Is a Putative Target Gene of Runx2 and Runx3

  2013cites this paper
• Chapter 17 – Cell–ECM Interactions in Repair and Regeneration

  2013cites this paper
• New insights into the functions of histidine-rich glycoprotein.

  2013cites this paper
• CD36 Ectodomain Phosphorylation Blocks Thrombospondin-1 Binding: Structure-Function Relationships and Regulation by Protein Kinase C

  2012cites this paper
• The use of Thrombospondin-1 Mimetic Peptides for the Treatment of Epithelial Ovarian Cancer

  2012cites this paper
• CD 36 Ectodomain Phosphorylation Blocks Thrombospondin-1 Binding Structure-Function Relationships and Regulation by Protein Kinase C

  2012cites this paper
• Histidine-rich glycoprotein polymorphism and pregnancy outcome: a pilot study.

  2011cites this paper
• Histidine-Rich Glycoprotein: A Possible Modulator of Coagulation and Fibrinolysis

  2011cites this paper
• Expression, purification and structural characterization of functionally replete thrombospondin-1 type 1 repeats in a bacterial expression system.

  2011cites this paper
• Cell–ECM Interactions in Repair and Regeneration

  2011cites this paper
• Clinical significance of serum levels of sCD36 in patients with systemic sclerosis: preliminary data.

  2011cites this paper
• Régulation de l'activité transcriptionnelle de PPARgamma via l'activation des récepteurs CD36 et GHS-R1a : potentiel anti-athérosclérotique

  2010cites this paper
• Genome‐wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene

  2010cites this paper
• Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.

  2010influential citation
• Role of class A human thrombospondins in the clearance of dying cells and tolerance induction

  2010cites this paper
• Thrombospondin‐1‐induced apoptosis of brain microvascular endothelial cells can be mediated by TNF‐R1

  2009cites this paper
• Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress

  2009cites this paper
• Mechanisms of Vessel Branching: Filopodia on Endothelial Tip Cells Lead the Way

  2009cites this paper
• Angiogenesis in cutaneous disease: part I.

  2009cites this paper
• Thrombospondins function as regulators of angiogenesis

  2009cites this paper
• A review of the ADAMTS family, pharmaceutical targets of the future.

  2009cites this paper
• Role of unusual O-glycans in intercellular signaling.

  2009cites this paper
• Untersuchungen zur antiangiogenen Aktivität des matrizellulären Proteins Thrombospondin-2

  2008cites this paper
• Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.

  2008cites this paper
• Editorial: Angiogenesis agents.

  2007cites this paper